Metastasis as a therapeutic target in prostate cancer: a conceptual framework

Area of Science:

• Oncology
• Cancer Metastasis Research

Background:

• Prostate cancer metastasis is the primary cause of cancer-related mortality.
• Current therapies primarily target primary tumors, not metastatic spread.
• Existing treatments for metastatic cancer were developed for primary tumor inhibition, overlooking distinct metastatic processes.

Purpose of the Study:

• To review conceptual, cellular, and molecular targets for effective anti-metastatic therapies.
• To highlight the need for therapies specifically designed to impede cancer spread.
• To address the limitations of current treatments in targeting secondary metastatic lesions.

Main Methods:

• Literature review of existing research on prostate cancer metastasis.
• Analysis of conceptual, cellular, and molecular targets for anti-metastatic drug development.
• Synthesis of information to guide the design of novel therapeutic strategies.

Main Results:

• Identified a critical gap in current prostate cancer treatment regarding metastatic spread.
• Highlighted that primary tumor growth inhibition does not equate to metastatic lesion control.
• Established the distinct biological processes involved in primary tumor progression versus metastatic development.

Conclusions:

• Effective anti-metastatic therapies require targeting distinct cellular and molecular pathways.
• A paradigm shift is needed from primary tumor-centric treatments to metastasis-focused strategies.
• Future research should prioritize the identification and validation of novel anti-metastatic targets.